Skip to main content
Chiome Bioscience Inc. logo

Chiome Bioscience Inc. — Investor Relations & Filings

Ticker · 4583 ISIN · JP3205350006 T Professional, scientific and technical activities
Open in API
Filings indexed 70 across all filing types
Latest filing 2018-03-26 Annual Report
Country JP Japan
Listing T 4583

About Chiome Bioscience Inc.

https://www.chiome.co.jp/

Chiome Bioscience Inc. is a clinical-stage biotechnology company specializing in the research and development of antibody-based therapeutics. The company leverages its proprietary ADLib® system, an innovative antibody generation technology, to discover and develop fully human monoclonal antibodies. Its primary mission is to address unmet medical needs by creating novel antibody drugs. The company's operations focus on the early stages of the drug discovery and development process, including initial research and early-phase clinical trials.

Recent filings

Filing Released Lang Actions
有価証券報告書－第14期(平成29年1月1日－平成29年12月31日)
Annual Report Classification · 1% confidence The document is a Japanese 'Yuka Shoken Hokokusho' (Securities Report), which is the Japanese equivalent of a 10-K. It contains detailed financial statements, business descriptions, and management analysis for the fiscal year ending December 31, 2017. It is a comprehensive annual filing, not an announcement or a summary. FY 2017
2018-03-26 Japanese
四半期報告書－第14期第3四半期(2017/07/01－2017/09/30)
Interim / Quarterly Report Classification · 1% confidence The document is a 'Quarterly Report' (四半期報告書) for Chiome Bioscience Inc., covering the third quarter of the 14th fiscal period (July 1, 2017, to September 30, 2017). It contains detailed financial statements, including the balance sheet and income statement, as well as management's analysis of the financial results. This fits the definition of an Interim/Quarterly Report (IR) as it provides comprehensive financial data for a period shorter than a full fiscal year. 9M 2017
2017-11-14 Japanese
四半期報告書－第14期第2四半期(2017/04/01－2017/06/30)
Interim / Quarterly Report Classification · 1% confidence The document is a 'Quarterly Report' (四半期報告書) filed by Chiome Bioscience Inc. in Japan. It contains detailed financial statements (balance sheet, income statement) for the second quarter of the fiscal year 2017. It is a formal regulatory filing submitted to the Kanto Local Finance Bureau under the Financial Instruments and Exchange Act. As it contains substantive financial data and analysis for an interim period, it is classified as an Interim/Quarterly Report (IR). Q2 2017
2017-08-10 Japanese
四半期報告書－第14期第1四半期(2017/01/01－2017/03/31)
Interim / Quarterly Report Classification · 1% confidence The document is a 'Quarterly Report' (四半期報告書) for Chiome Bioscience Inc., covering the period from January 1, 2017, to March 31, 2017. It contains detailed financial statements, including the balance sheet and income statement, and management's analysis of the financial results. It is not an announcement or a certification, but the full interim report itself, which fits the definition of an Interim/Quarterly Report (IR). Q1 2017
2017-05-15 Japanese
有価証券報告書－第13期(2016/01/01－2016/12/31)
Annual Report
2017-03-29 Japanese
四半期報告書－第13期第3四半期(2016/07/01－2016/09/30)
Interim / Quarterly Report Classification · 1% confidence The document is a '第３四半期報告書' (Third Quarter Report) for Chiome Bioscience Inc., covering the period from July 1, 2016, to September 30, 2016. It contains detailed financial statements, management analysis, and business status updates, which are characteristic of an interim/quarterly report under Japanese financial regulations (Financial Instruments and Exchange Act). Q3 2016
2016-11-14 Japanese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.